Astrocytoma

An astrocytoma is a type of brain tumor. It starts in the astrocytes, which are support cells in the brain. These tumors can range from slow-growing to very aggressive. They are often found in children but can also occur in adults.

Condition

What people with Astrocytoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Astrocytoma?

NameHow it went

About Astrocytoma

What It Is

An astrocytoma is a tumor that starts in the brain or spinal cord from glial cells, the cells that support and protect nerve cells. It belongs to a larger family of tumors called gliomas. Symptoms depend on where the tumor sits and what that part of the brain controls. Common ones include seizures, headaches (often worse in the morning or eased after vomiting), weakness, changes in vision or speech, trouble with balance, and changes in memory, mood or personality. Astrocytomas vary widely, and the type and grade matter more than the name alone. Grade describes how quickly the tumor is likely to grow. Pilocytic astrocytoma (grade 1) grows slowly, usually stays in one place and is most common in children. Diffuse astrocytomas (grade 2) also grow slowly but spread threads of tumor into surrounding brain, which makes them hard to remove completely. Grade 3 and grade 4 astrocytomas grow faster and are more serious. Glioblastoma, a fast-growing tumor with a different genetic profile, is now classified as a related but separate diagnosis.

Causes & Risk Factors

For most people, no cause is found, and nothing they did or failed to do brought on the tumor. There are no known ways to prevent it. A few factors raise risk. Some inherited conditions are linked to astrocytomas, including neurofibromatosis type 1 (NF1), tuberous sclerosis, Li-Fraumeni syndrome and Lynch syndrome. Children with NF1 can develop slow-growing tumors along the nerves that carry vision, and children with tuberous sclerosis can develop a specific low-grade type called subependymal giant cell astrocytoma. Previous radiation to the head is a rare cause. Most people with these risk factors never develop a brain tumor, and most people who do have none of them. When a family syndrome is suspected, genetic counseling can help relatives understand their own risk.

How It's Diagnosed

Assessment starts with a history and a neurological exam, which checks strength, sensation, coordination, vision and thinking. The key imaging test is an MRI (magnetic resonance imaging) of the brain or spine, done before and after a contrast dye is injected into a vein. MRI shows where the tumor is and how large it is, but it cannot reliably say what kind of tumor it is. That usually requires tissue, taken either during surgery to remove the tumor or through a biopsy, in which a needle guided by imaging removes a small sample. A pathologist looks at the cells under a microscope and runs molecular tests on them. One of the most important is for a change in a gene called IDH (isocitrate dehydrogenase). Whether a diffuse astrocytoma is IDH-mutant, along with a few other genetic markers, now shapes the formal diagnosis, the grade, the expected course and which treatments make sense. When a tumor sits where a biopsy would be unsafe, doctors sometimes have to rely on imaging alone.

Treatment Options

Treatment depends on the tumor's type, grade, molecular markers and location, as well as the person's age and overall health. Care is usually planned by a team that includes a neurosurgeon, a neuro-oncologist and a radiation oncologist. Surgery is usually the first step. For a pilocytic astrocytoma, removing the whole tumor can be enough, and radiation may be added if some remains. Diffuse astrocytomas cannot be cured by surgery because tumor cells extend beyond what can be seen. The goal is to remove as much as can be taken safely, because preserving speech, movement and thinking matters more than removing every last bit. After surgery for a grade 2 IDH-mutant astrocytoma, some people are closely watched with regular scans. Vorasidenib (Voranigo), a daily pill that blocks the abnormal IDH enzyme, is approved for people 12 and older with these tumors after surgery. In the main trial, it more than doubled the typical time before the tumor grew on scans (about 28 months versus 11 on placebo) and delayed the need for radiation or chemotherapy. Whether it lengthens life is not yet known, and it requires regular liver blood tests because it can cause liver injury. When a tumor is higher grade or keeps growing, radiation therapy followed by chemotherapy is standard. Temozolomide (Temodar), an oral chemotherapy, is commonly used for grade 3 tumors. For grade 2 tumors needing treatment, a three-drug combination called PCV (procarbazine, lomustine and vincristine) after radiation has extended survival by years in a long-term trial. These treatments lower blood counts and can affect energy, memory and thinking over time, so the timing of radiation is often weighed carefully. Steroid medicines can reduce swelling around the tumor, ideally for as short a time as possible, and anti-seizure medicines help control seizures. Children with low-grade tumors that cannot be removed may receive chemotherapy or targeted drugs matched to the tumor's genetic changes. Clinical trials are an option at many stages.

What to Expect

The outlook varies more with astrocytoma than with most diagnoses. A pilocytic astrocytoma that can be removed completely often never causes trouble again. A diffuse grade 2 astrocytoma tends to grow slowly over years, and many people keep working and following their usual routines for long periods, though these tumors usually grow again eventually and can become higher grade. Grade 3 and 4 tumors are more serious, and the course is shorter and harder. Younger age and good day-to-day function at diagnosis are linked to better outcomes. Follow-up MRI scans are a long-term part of life, often every few months at first and less often when things stay stable. Changes on a scan in the first months after radiation can be a treatment effect rather than true growth, so doctors sometimes repeat the scan before changing course. Fatigue, memory and concentration problems, and seizures are common challenges. Physical, occupational and speech therapy, counseling and palliative care (support focused on symptoms and quality of life, which can begin at any stage) all help. Children treated for astrocytoma need longer-term follow-up for effects on growth, hormones, vision and learning.

When to Seek Help

See a doctor if headaches, seizures, weakness, vision or speech changes, balance problems, or changes in personality or memory appear and persist, especially when several occur together or keep getting worse. A first seizure should always be evaluated promptly. If you are already being treated, contact your care team right away for new or worsening weakness, speech, vision or thinking problems, seizures that become more frequent, or headaches with vomiting or unusual sleepiness. These can signal tumor growth, swelling or a treatment effect, and often prompt a new scan. Also call promptly for fever or bleeding during chemotherapy, or yellowing of the skin or eyes while taking vorasidenib. Call 911 if a seizure lasts longer than 5 minutes or if seizures repeat without the person waking up in between.

Questions to Ask Your Doctor

  1. 1.What type and grade is my tumor, and what do its molecular test results, such as IDH status, mean for my outlook?
  2. 2.How much of the tumor can be removed safely, and what functions could surgery affect?
  3. 3.Is close monitoring, vorasidenib, or radiation with chemotherapy the right next step for me, and what are the trade-offs of starting now versus waiting?
  4. 4.How often will I need MRI scans, and what changes should prompt me to call before my next appointment?
  5. 5.What support is available for seizures, driving, work, memory problems and my family?

Last reviewed • Oct 2026

Educational content, not medical advice.